A substudy within AMIO-CAT measuring brain natriuretic peptide suggested that biomarkers may improve identification of patients at risk for recurrent AF,31 pointing potentially towards personalized or stratified selection of patients for specific rhythm control therapies.32 Here, NPPB is linked to atrial fibrillation.